from web site
Ames, F. R. and Cridland, S. Anticonvulsant impact of cannabidiol. S.Afr. Medication. J. 1-4-1986; 69( 1 ):14. View abstract. Barnes, M. P. Sativex: clinical efficacy and tolerability in the treatment of symptoms of several sclerosis and neuropathic discomfort. Expert. Opin. Pharmacother. 2006; 7( 5 ):607 -615. View abstract. Carlini, E. A. and Cunha, J. M. Hypnotic and antiepileptic effects of cannabidiol.
View abstract. Collin, C., Davies, P., Mutiboko, I. K., and Ratcliffe, S. Randomized managed trial of cannabis-based medication in spasticity triggered by multiple sclerosis. Eur. J.Neurol. 2007; 14( 3 ):290 -296. View abstract. Collin, C., Ehler, E., Waberzinek, G., Alsindi, Z., Davies, P., Powell, K., Notcutt, W., O'Leary, C., Ratcliffe, S., Novakova, I., Zapletalova, O., Pikova, J., and Ambler, Z.
Neurol. Res. 2010; 32( 5 ):451 -459. View abstract. Consroe, P., Kennedy, K., and Schram, K. Assay of plasma cannabidiol by capillary gas chromatography/ion trap mass spectroscopy following high-dose duplicated daily oral administration in human beings. Pharmacol Biochem. Behav. 1991; 40( 3 ):517 -522. View abstract. Consroe, P., Laguna, J., Allender, J., Snider, S., Stern, L., Sandyk, R., Kennedy, K., and Schram, K.
Pharmacol Biochem. Behav. 1991; 40( 3 ):701 -708. View abstract. Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., and Mechoulam, R. Persistent administration of cannabidiol to healthy volunteers and epileptic clients. Pharmacology 1980; 21( 3 ):175 -185. View abstract. Harvey, D. J., Samara, E., and Mechoulam, R.
Pharmacol Biochem. Behav. 1991; 40( 3 ):523 -532. View abstract. Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., and Izzo, A. A. Neuroprotective effect of cannabidiol, a non-psychoactive part from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells. J Neurochem. 2004; 89( 1 ):134 -141. View abstract. Ohlsson, A., Lindgren, J. E., Andersson, S., Agurell, S., Gillespie, H., and Hollister, L.
Single-dose kinetics of deuterium-labelled cannabidiol in guy after smoking cigarettes and intravenous administration. Biomed. Environ Mass Spectrom. 1986; 13( 2 ):77 -83. View abstract. Srivastava, M. D., Srivastava, B. I., and Brouhard, B. Delta9 tetrahydrocannabinol and cannabidiol change cytokine production by human immune cells. Immunopharmacology 1998; 40( 3 ):179 -185. View abstract. Trembly B, Sherman M. Double-blind medical study of cannabidiol as a secondary anticonvulsant.
Wade, D. T., Collin, C., Stott, C., and Duncombe, P. Did you see this? -analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with several sclerosis. Mult. Scler. 2010; 16( 6 ):707 -714. View abstract. Wade, D. T., Makela, P., Robson, P., House, H., and Bateman, C. Do cannabis-based medical extracts have basic or particular effects on signs in several sclerosis? A double-blind, randomized, placebo-controlled study on 160 clients.